- Venus Global Fulfillment Center (VGFC) strengthens global supply chain with capacity to process 10,000 orders per day, ensuring timely access to critical medicines worldwide
Chandigarh, October 15, 2025: Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), one of the world’s top 10 fixed-dosage injectable manufacturers, has announced the inauguration of its state-of-the-art Venus Global Fulfillment Center (VGFC).
Spanning 1,32,000 sq. ft. with a built-up area of 66,000 sq. ft., the facility marks a major leap in the company’s logistics and supply chain infrastructure, enabling efficient, reliable, and compliant medicine distribution across global markets.
Built to Global Standards of Excellence
The VGFC operates in full compliance with international pharmaceutical norms, including WHO GDP, EU GMP, PAHO, CDSCO, GDP AEO, and ISO certifications.
Designed to preserve product integrity and quality, it ensures seamless delivery across both regulated and semi-regulated markets worldwide.
High-Capacity Operations with Advanced Automation
Equipped with cutting-edge automation and smart logistics technologies, VGFC can process up to 10,000 orders per day across B2B and B2C channels.
Currently operating at around 30,000 orders per month, the facility features:
-
Temperature-controlled storage zones
-
RFID and barcode-based tracking systems
-
Automated sorting and retrieval technologies
-
Storage capacity for 5,000+ pallets and over 50 million product units
This advanced infrastructure enables Venus Remedies to anticipate global demand and ensure on-time, compliant, and precise order fulfillment.
Leadership Speaks: Strengthening Global Healthcare Access
Saransh Chaudhary, President, Global Critical Care, Venus Remedies Ltd., and CEO, Venus Medicine Research Centre, said:
“The VGFC represents a strategic advancement in our global supply framework. It enhances our responsiveness to urgent healthcare needs and ensures uninterrupted patient access across more than 100 countries.”
Aditi K. Chaudhary, President, International Business, Venus Remedies Ltd., added:
“Every process within VGFC has been designed for speed, transparency, and consistency. From inventory management to final dispatch, we are committed to upholding the highest standards of quality and reliability.”
Peeyush Jain, Deputy Managing Director and Head of Supply Chain, Venus Remedies Ltd., commented:
“By combining automation with skilled human oversight, VGFC brings agility and precision to our operations. It strengthens our ability to respond rapidly to market demands, ensuring critical medicines reach patients on time, every time.”
Aligned with Sustainability and Operational Excellence
The VGFC is also a reflection of Venus Remedies’ commitment to sustainability, featuring:
-
Energy-efficient HVAC systems
-
Rainwater harvesting
-
Authorized waste management practices
-
Eco-conscious logistics and operations
This integrated approach balances operational excellence with environmental responsibility.
Advancing Global Reach and Patient Care
Through VGFC, Venus Remedies enhances its supply capability across critical care, oncology, and antimicrobial therapy segments.
The facility reinforces the company’s vision to deliver safe, high-quality medicines with reliability and global reach, supporting improved patient outcomes worldwide.
About Venus Remedies Ltd.
Website: www.venusremedies.com
Headquartered in Panchkula, Venus Remedies Ltd. (NSE: VENUSREM, BSE: 526953) is among the top 10 fixed-dosage injectable manufacturers globally, with a presence in 90+ countries and a portfolio of 75+ products across Europe, Australia, Africa, Asia-Pacific, the Middle East, Latin America, and the Caribbean.
With nine globally benchmarked facilities in India and Germany and 11 international marketing offices, the company holds approvals from European GMP (INFARMED), PIC/S (Malaysia & Ukraine), SAHPRA, UNICEF, TGA, INVIMA, and WHO-GMP, alongside multiple ISO certifications.
Venus Remedies is also a pioneer in combating antimicrobial resistance (AMR) through its Venus Medicine Research Centre (VMRC), spearheading initiatives like GASAR (Global AMR Surveillance and Research) and the PLEA Trust to promote antibiotic stewardship.
As a member of the AMR Industry Alliance, India AMR Innovation Hub, and Vivli AMR Registry, Venus Remedies actively contributes to global AMR policy, research, and innovation.
